Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data

Willan, Andrew R., Briggs, Andrew H., Hoch, Jeffrey S.·2004·Health Economics

Cited by (364)

Items 201–300 of 364

  1. Six-month cost-effectiveness of adding motivational interviewing or a stratified vocational advice intervention to usual case management for workers with musculoskeletal disorders: the MI-NAV economic evaluation
    Alexander Tingulstad, Esther T. Maas, Tarjei Langseth Rysstad, Britt Elin Øiestad, Fiona Aanesen, Are Hugo Pripp, Maurits W. van Tulder, Margreth Grotle · 2023 · Journal of Occupational Medicine and Toxicology
  2. Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected type 2 diabetes: a randomised controlled trial
    Mike Sampson, Allan Clark, Max Oscar Bachmann, Nikki J. Garner, Lisa Irvine, Amanda Caroline Howe, Colin James Greaves, Sara Auckland, Jane Rebecca Smith, Jeremy J. O. Turner et al. · 2021 · BMC Medicine
  3. Cost-Effectiveness of an Online Intervention for Caregivers of People Living With Dementia
    Catherine Henderson, Martin Richard John Knapp, Jane Fossey, Eleni Frangou, Clive G. Ballard · 2022 · Journal of the American Medical Directors Association
  4. Clinical and cost-effectiveness of a guided internet-based Acceptance and Commitment Therapy to improve chronic pain-related disability in green professions (PACT-A): Study protocol of a pragmatic randomised controlled trial
    Terhorst, Yannik, Braun, Lina, Titzler, Ingrid, Buntrock, Claudia, Freund, Johanna, Thielecke, Janika, Ebert, David, Baumeister, Harald · 2020 · BMJ Open
  5. A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
    Sube Banerjee, Nicolas Farina, Catherine Henderson, Juliet High, Susan Stirling, Lee Shepstone, Julia Fountain, Clive G. Ballard, Peter Bentham, Alistair S. Burns et al. · 2023 · Health Technology Assessment
  6. Tonsillectomy compared with conservative management in patients over 16 years with recurrent sore throat: the NATTINA RCT and economic evaluation
    Janet Ann Wilson, Tony Fouweather, Deborah D. Stocken, Tara Marie Homer, Catherine Haighton, Nikki S. Rousseau, James O’Hara, Luke David Vale, Rebecca Wilson, Sonya C. Carnell et al. · 2023 · Health Technology Assessment
  7. Bayesian Regression Model for a Cost-Utility and Cost-Effectiveness Analysis Comparing Punch Grafting Versus Usual Care for the Treatment of Chronic Wounds
    Carmen Selva-Sevilla, Elena Conde‐Montero, Manuel Gerónimo‐Pardo · 2020 · International Journal of Environmental Research and Public Health
  8. An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial)*
    Tracey Sach, Kim Suzanne Thomas, Jonathan Batchelor, Perways Akram, Joanne R Chalmers, Rachel Haines, Garry Meakin, Lelia Duley, Jane Ravenscroft, Andy Rogers et al. · 2020 · British Journal of Dermatology
  9. Longer-term survival, quality of life, and cost-effectiveness of conservative versus liberal oxygenation targets in critically ill children: a pre-specified analysis from Oxy-PICU, a multicentre, open, parallel-group, randomised controlled trial
    Silvia Moler Zapata, Mark John Peters, Doug William Gould, Elisa Giallongo, Marzena Orzol, Samiran Ray, Karen Thomas, Irene Chang, Lauran O’Neill, Rachel Agbeko et al. · 2024 · The Lancet Child & Adolescent Health
  10. Cost-effectiveness of craniotomy versus decompressive craniectomy for UK patients with traumatic acute subdural haematoma
    Sarah Pyne, Garry Barton, David Turner, Harry Mee, BARBARA A. GREGSON, Angelos Georgiou Kolias, Carole L. Turner, Hadie Adams, Midhun Mohan, Christopher E. G. Uff et al. · 2024 · BMJ Open
  11. Volatile vs Total intravenous Anaesthesia for major non-cardiac surgery: a pragmatic randomised triaL (VITAL)
    Joyce Yeung, Shaman Jhanji, John Braun, Janet Dunn, Lucy Eggleston, Samuel Frempong, Louise Hiller, Claire Jacques, Monica L Jefford, James M. Mason et al. · 2024 · Trials
  12. Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
    Lucy E. Bradshaw, Laura A. Wyatt, Sara Brown, Rachel Haines, Alan A. Montgomery, Michael Richard Perkin, Tracey Sach, Sandra Lawton, Carsten Flohr, Matthew J Ridd et al. · 2024 · Health Technology Assessment
  13. Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT
    Miriam Santer, Megan M. Lawrence, Sarah Pyne, Susanne Renz, Beth L. Stuart, Tracey Sach, Matthew J Ridd, Kim Suzanne Thomas, Jacqueline Nuttall, Natalia Vadimovna Permyakova et al. · 2024 · Health Technology Assessment
  14. Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
    Qi Cao, Erik Buskens, Hans L. Hillege, Tiny Jaarsma, Maarten Jacobus Postma, Douwe Postmus · 2018 · The European Journal of Health Economics
  15. The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?
    Ângela Jornada Ben, Johanna Maria van Dongen, Mohamed El Alili, Martijn W. Heymans, Jos W. R. Twisk, Janet L. MacNeil Vroomen, Maartje de Wit, Susan E.M. van Dijk, Teddy Oosterhuis, Judith Ekkina Bosmans · 2022 · The European Journal of Health Economics
  16. Cost-Effectiveness Analysis of Complementary and Alternative Medicine in Treating Anxiety Disorders
    Matthew Kutch · 2016 · Alternative & Integrative Medicine
  17. Machine Learning for Precision Health Economics and Outcomes Research (P-HEOR): Conceptual Review of Applications and Next Steps
    Yixi Chen, Viktor Chirikov, Xiaocong Li Marston, Jingang Yang, Haibo Qiu, Jianfeng Xie, Ning Sun, Changming Gu, Peng Dong, Xin Yuan Gao · 2020 · Journal of health economics and outcomes research
  18. Cost-effectiveness of an Evidence-Based Childhood Asthma Intervention in Real-World Primary Care Settings
    Avi Dor, Qian Luo, Maya Tuchman Gerstein, Floyd J. Malveaux, Herman Mitchell, Anne Rossier Markus · 2018 · Journal of Ambulatory Care Management
  19. Social recovery therapy for young people with emerging severe mental illness: the Prodigy RCT
    Fowler, David, Berry, Clio, Hodgekins, Joanne, Banerjee, Robin, Barton, Garry, Byrne, Rory, Clarke, Timothy, Fraser, Rick, Grant, Kelly, Greenwood, Kathryn et al. · 2021 · Health Technology Assessment
  20. Examining the Heterogeneity and Cost Effectiveness of a Complex Intervention by Segmentation of Patients with Chronic Obstructive Pulmonary Disease
    Sabrina Storgaard Sørensen, Morten Berg Jensen, Kjeld Møller Pedersen, Lars Holger Ehlers · 2017 · Value in Health
  21. Evaluating Quality-of-Life, Length of Stay and Cost-Effectiveness of a Front-Door Geriatrics Program: An Exploratory Proof-of-Concept Study
    Michelle Jessica Pereira, Edward Kah Chun Chong, Joseph Antonio D Molina, S.H.X. Ng, E.F. Goh, Birong Zhu, M. Chan, Wee Shiong Lim · 2022 · The Journal of Frailty & Aging
  22. Long-Term Outcomes and Cost-Effectiveness of an Internet-Based Self-Help Intervention for Social Anxiety Disorder in University Students: Results of a Randomized Controlled Trial
    Fanny Kählke, Claudia Buntrock, Filip Smit, Thomas Berger, Harald Baumeister, David Daniel Ebert · 2023 · Depression and Anxiety
  23. Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT
    Bart Fabian Seppen, Marjolein J.E. Greuter, Jimmy Wiegel, Marieke M. ter Wee, Maarten Boers, Michael Twahier Nurmohamed, Wouter H Bos · 2023 · Lara D. Veeken
  24. Emollients for preventing atopic eczema: Cost‐effectiveness analysis of the BEEP trial
    Tracey Sach, Stella T. Lartey, Charlotte F. Davies, Joanne R Chalmers, Rachel Haines, Lucy E. Bradshaw, Alan A. Montgomery, Kim Suzanne Thomas, Sara Brown, Matthew J Ridd et al. · 2023 · Clinical & Experimental Allergy
  25. Cost-effectiveness of providing university students with a mindfulness-based intervention to reduce psychological distress: economic evaluation of a pragmatic randomised controlled trial
    Adam P. Wagner, Julieta Galante, Géraldine Dufour, Garry Barton, Jan Štochl, Maris Vainre, Peter Brian Jones · 2023 · BMJ Open
  26. Cost‐effectiveness of the psycho‐educational blended (group and online) intervention HypoAware compared with usual care for people with Type 1 and insulin‐treated Type 2 diabetes with problematic hypoglycaemia: analyses of a cluster‐randomized controlled trial
    Maartje de Wit, Stefanie M.P.A. Rondags, Maurits W. van Tulder, Frank Jan Snoek, Judith Ekkina Bosmans · 2017 · Diabetic Medicine
  27. A Review of Heterogeneity in Comparative Economic Analysis, with Specific Considerations for the Decentralized US Setting and Patient-Centered Care
    Michael S. Willis, Andreas Nilsson, Cheryl A. Neslusan · 2025 · PharmacoEconomics
  28. The Care Home Independent Pharmacist Prescriber Study (CHIPPS): development and implementation of an RCT to estimate safety, effectiveness and cost-effectiveness
    David John Wright, Richard Holland, David Phillip Alldred, Christine M Bond, Carmel M Hughes, Garry Barton, Fiona Mary Poland, Lee Shepstone, Antony J Arthur, Linda Birt et al. · 2023 · Programme Grants for Applied Research
  29. Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature
    Gemma Shields, Paul Clarkson, Ash Bullement, Warren Stevens, Mark Wilberforce, Tracey M. Farragher, Arpana Verma, Linda Mary Davies · 2024 · PharmacoEconomics
  30. A smoking cessation smartphone app that delivers real-time ‘context aware’ behavioural support: the Quit Sense feasibility RCT
    Felix Naughton, Aimie Hope, Chloë Brown, Kelly Grant, Caitlin Jade Notley, Antony Colles, Claire West, Cecilia Mascolo C, Tim J Coleman, Garry Barton et al. · 2024 · Public Health Research
  31. Cost-effectiveness of high flow nasal cannula therapy versus continuous positive airway pressure for non-invasive respiratory support in paediatric critical care
    Zia Sadique, Silvia Moler Zapata, Richard Grieve, Alvin Richards‐Belle, Izabella Lawson, Robert Darnell, Julie Lester, Kevin Morris, Lyvonne Nicole Tume, Peter J. Davis et al. · 2024 · Critical Care
  32. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren’s contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation
    Joseph J. Dias, Puvan Tharmanathan, Catherine Arundel, Charlie Welch, Qi Wu, Paul A. Leighton, Maria Armaou, Belén Corbacho, Nick A. Johnson, Sophie James et al. · 2024 · Health Technology Assessment
  33. Measurement of total hemoglobin reduces red cell transfusion in hospitalized patients undergoing cardiac surgery: a retrospective database analysis
    Christopher Craver, Kathy W. Belk, Gerard J. Myers · 2017 · Perfusion
  34. Cost-effectiveness analysis of domiciliary topical sevoflurane for painful leg ulcers
    Carmen Selva-Sevilla, FD Fernández-Ginés, Manuel Cortiñas‐Sáenz, Manuel Gerónimo‐Pardo · 2021 · PLoS ONE
  35. Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions
    Reka E. Pataky, Stirling Bryan, Mohsen Sadatsafavi, Stuart J Peacock, Dean A. Regier · 2022 · PharmacoEconomics
  36. Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial
    Sarah Pyne, Tracey Sach, Megan M. Lawrence, Susanne Renz, Zina B. Eminton, Beth L. Stuart, Kim Suzanne Thomas, Nick A Francis, Irene Soulsby, Karen Thomas et al. · 2023 · BMJ Open
  37. Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care – Protocol for a health economic evaluation alongside a randomized controlled trial
    Helene Eckhardt, Wilm Quentin, Julia Silzle, Reinhard Busse, Tanja Rombey · 2024 · BMC Geriatrics
  38. Bayesian cost-effectiveness analysis for censored data: an application to antiplatelet therapy
    David Bin-Chia Wu, Yi‐Wen Tsai, Yu‐Wen Wen · 2011 · Journal of Medical Economics
  39. Ab Initio Molecular Dynamics with Quantum Monte Carlo
    Ye Luo, Sandro Sorella · 2015 · Frontiers in Materials
  40. Reduction of routine use of radiography in patients with ankle fractures leads to lower costs and has no impact on clinical outcome: an economic evaluation
    Pieter van Gerven, Johanna Maria van Dongen, Sidney M. Rubinstein, M. F. Termaat, Mostafa El Moumni, Wietse P. Zuidema, Pieta Krijnen, Inger Birgitta Schipper, Maurits W. van Tulder, on behalf of the WARRIOR study group et al. · 2020 · BMC Health Services Research
  41. Why the Gap in Evaluating the Social Constructs and the Value of Medicines?
    Jacquelyn McRae, Eberechukwu Onukwugha · 2021 · PharmacoEconomics
  42. A supported self-help for recurrent depression in primary care; An economic evaluation alongside a multi-center randomised controlled trial
    Karolien E.M. Biesheuvel-Leliefeld, Judith Ekkina Bosmans, Sandra M.A. Dijkstra‐Kersten, Filip Smit, Claudi Bockting, Anneke van Schaik, Harm van Marwijk, Henriëtte Eveline van der Horst · 2018 · PLoS ONE
  43. Gesundheitsökonomische Evaluation in der psychiatrischen Versorgungsforschung
    Reinhold Kilian · 2008 · Prävention und Gesundheitsförderung
  44. [Intra-oral and peri-oral piercing].
    Yehuda Zadik, Talia Becker, Liran Levin · 2007 · PubMed
  45. Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people
    Tracey Sach, Mary Onoja, Holly Clarke, Miriam Santer, Ingrid Müller, Taeko Becque, Beth L. Stuart, Julie Hooper, Mary Steele, Sylvia Wilczynska et al. · 2024 · The European Journal of Health Economics
  46. Evaluation of adapted parent training for challenging behaviour in pre-school children with moderate to severe intellectual developmental disabilities: A randomised controlled trial
    Rachel Royston, Michael Absoud, Gareth Ambler, Jacqueline Barnes, Rachael Maree Hunter, Marinos Kyriakopoulos, Tamara Ondrušková, Kate Oulton, Eleni Paliokosta, Monica Panca et al. · 2024 · PLoS ONE
  47. Cost-effectiveness and cost-utility analysis of a nurse-led, transitional care model to improve care coordination for patients with cardiovascular diseases: results from the “Cardiolotse” study
    Marie Coors, Wiebke Schüttig, Katrin Christiane Reber, Harald Darius, Alfred Holzgreve, Sebastian Karmann, Anica Stürtz, Rebecca Zöller, Saskia Kropp, Petra Riesner et al. · 2024 · The European Journal of Health Economics
  48. Randomised controlled trial with economic and process evaluations of domiciliary welfare rights advice for socioeconomically disadvantaged older people recruited via primary health care (the Do-Well study)
    Catherine Haighton, Suzanne M Moffatt, Denise Howel, Mel Steer, Frauke Becker, Andrew Bryant, Sarah Lawson, Elaine McColl, Luke David Vale, Eugene M. G. Milne et al. · 2019 · Public Health Research
  49. A Latent Class Approach to Modeling Trajectories of Health Care Cost in Pediatric Cystic Fibrosis
    Joseph F Levy, Marjorie A. Rosenberg · 2019 · Medical Decision Making
  50. Physical activity trails in an urban setting and cardiovascular disease morbidity and mortality in Winnipeg, Manitoba, Canada: a study protocol for a natural experiment
    Erin P. Hobin, Anders Swanson, Gillian L. Booth, Kelly F Russell, Laura C. Rosella, Brendan T. Smith, Ed Manley, Wanrudee Isaranuwatchai, Stephanie Whitehouse, Nicole M. Brunton et al. · 2020 · BMJ Open
  51. Cost-effectiveness of single-layer versus double-layer uterine closure during caesarean section on postmenstrual spotting: economic evaluation alongside a randomised controlled trial
    Sanne I. Stegwee, Ângela Jornada Ben, Mohamed El Alili, Lucet F. van der Voet, Christianne J.M. de Groot, Judith Ekkina Bosmans, Judith A.F. Huirne · 2021 · BMJ Open
  52. Effectiveness and cost-effectiveness of a web-based routine assessment with integrated recommendations for action for depression and anxiety (RehaCAT+): protocol for a cluster randomised controlled trial for patients with elevated depressive symptoms in rehabilitation facilities
    Johannes Knauer, Yannik Terhorst, Paula Philippi, Selina M. Kallinger, Sandro Eiler, Reinhold Kilian, Tamara Waldmann, Morten Moshagen, Martina Bader, Harald Baumeister · 2022 · BMJ Open
  53. Economic Evaluation of Intensive Inpatient Treatments for Severely Obese Children and Adolescents
    Sabine Makkes, Johanna Maria van Dongen, Carry Mira Renders, Olga H. van der Baan‐Slootweg, Jacob C. Seidell, Judith Ekkina Bosmans · 2017 · Obesity Facts
  54. Bayesian Variable Selection in Cost-Effectiveness Analysis
    Miguel Ángel Negrín, Francisco José Vázquez Polo, María del Carmen Martel Escobar, Elı́as Moreno, Francisco Javier Girón · 2010 · International Journal of Environmental Research and Public Health
  55. An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis.
    Rajan Sharma, Yuanyuan Gu, Kompal Sinha, Teresa Y. C. Ching, Vivienne Marnane, Lisa H. Gold, Melissa A Wake, Jing Wang, Bonny Parkinson · 2022 · PubMed
  56. A Tutorial on Net Benefit Regression for Real-World Cost-Effectiveness Analysis Using Censored Data from Randomized or Observational Studies
    Shuai Chen, Heejung Bang, Jeffrey S. Hoch · 2024 · Medical Decision Making
  57. Cancer patients’ needs assessment in primary care: study protocol for a cluster randomised controlled trial (cRCT), economic evaluation and normalisation process theory evaluation of the needs assessment tool cancer (CANAssess)
    Joseph Clark, Bethan J Copsey, Alexandra M. Wright-Hughes, Emma McNaught, Petra Bijsterveld, Terry McCormack, Robbie Foy, Scott Wilkes, Jon Mark Dickson, David M. Meads et al. · 2022 · BMJ Open
  58. Net‐benefit regression with censored cost‐effectiveness data from randomized or observational studies
    Shuai Chen, Jeffrey S. Hoch · 2022 · Statistics in Medicine
  59. Cost consequences analysis of early vocational rehabilitation compared with usual care for stroke survivors
    Sarah Pyne, Tracey Sach, Rory A. Cameron, Helen L. Risebro, Alexandra M. Wright-Hughes, Ellen Thompson, Caroline Leigh Watkins, Audrey Bowen, Judith Stevens, Amanda J Farrin et al. · 2024 · Clinical Rehabilitation
  60. Critical appraisal of cost-effectiveness and cost-utility studies in health care
    Marta O. Soares, Jo C Dumville · 2008 · Evidence-Based Nursing
  61. Econometric Considerations When Using the Net Benefit Regression Framework to Conduct Cost-effectiveness Analysis
    Jeffrey S. Hoch, Pierre Chaussé · 2018 · Emerald Group Publishing Limited eBooks
  62. Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non–muscle-invasive Bladder Cancer
    Anouk E. Hentschel, Christian J. Blankvoort, Judith Bosschieter, André N. Vis, R. Jeroen A. van Moorselaar, Judith Ekkina Bosmans, Jakko A. Nieuwenhuijzen · 2022 · European Urology Open Science
  63. The Cardiac Care Bridge transitional care program for the management of older high-risk cardiac patients: An economic evaluation alongside a randomized controlled trial
    Lotte Verweij, Adrianne C. M. Petri, Janet L. MacNeil Vroomen, Patricia Jepma, Corine H. M. Latour, Ron J.G. Peters, Wilma J.M. Scholte op Reimer, Bianca M. Buurman, Judith Ekkina Bosmans · 2022 · PLoS ONE
  64. Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon
    Helen‐Maria Vasiliadis, Catherine Lamoureux‐Lamarche, Alexandra Chapdelaine, Martin D. Provencher, Peter J. Norton, Djamal Berbiche, Pasquale Roberge · 2023 · The Canadian Journal of Psychiatry
  65. Subacromial spacers for adults with symptomatic, irreparable rotator cuff tears: the START:REACTS novel group sequential adaptive RCT
    Andrew John Metcalfe, Susanne Arnold, Helen M. Parsons, Nick Parsons, Gev Bhabra, Jaclyn Brown, Howard Bush, Michael Diokno, Mark T. Elliott, Josephine Fox et al. · 2023 · Efficacy and Mechanism Evaluation
  66. Cost-effectiveness of selective decontamination of the digestive tract to decrease infectious complications in colorectal cancer surgery: An analysis of the SELECT trial
    J. Reinder D. Reuvers, E. Gaikhorst, Ângela Jornada Ben, J. Scholten, Marjolein van Egmond, Judith Ekkina Bosmans, H. B. A. C. Stockmann, Geert Kazemier M, Jurriaan Benjamin Tuynman, Gabor S. A. Abis et al. · 2023 · European Journal of Surgical Oncology
  67. Cost-Utility of Attachment-Based Compassion Therapy (ABCT) and Mindfulness-Based Stress Reduction (MBSR) in the Management of Depressive, Anxious, and Adjustment Disorders in Mental Health Settings: Economic Evaluation Alongside a Randomized Controlled Trial
    Francesco D’Amico, Jaime Navarrete, Jesús Montero‐Marín, Eugenia Cardeñosa, Mayte Navarro‐Gil, Adrián Pérez‐Aranda, Yolanda López del Hoyo, Carlos Collado‐Navarro, Javier García‐Campayo, Juan Vicente Luciano · 2024 · Mindfulness
  68. Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size
    Kelvin Chan, Feng Xie, Andrew R. Willan, Eleanor Pullenayegum · 2017 · Medical Decision Making
  69. Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD: A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial
    Aureliano Paolo Finch, Patricia van Velzen, Gerben ter Riet, Peter J. Sterk, Jan M. Prins, Judith Ekkina Bosmans · 2018 · PharmacoEconomics
  70. Improving precision in cost-effectiveness analysis using copulas.
    Casey Quinn · 2007 · RePEc: Research Papers in Economics
  71. Bayesian Statistical Economic Evaluation Methods for Health Technology Assessment
    Andrea Gabrio, Gianluca Baio, Andrea Manca · 2019 · Oxford Research Encyclopedia of Economics and Finance
  72. The cost effectiveness of early assessment and intervention by a dedicated health and social care professional team for older adults in the emergency department compared to treatment-as-usual: Economic evaluation of the OPTI-MEND trial
    Dominic Trépel, Manuel Ruiz-Adame, Marica Cassarino, Elayne Ahern, Collette Devlin, Katie Robinson, Íde O’Shaughnessy, Gerard McCarthy, Cian Corcoran, Rose Galvin · 2024 · PLoS ONE
  73. A regression framework for a probabilistic measure of cost‐effectiveness
    Nicholas Illenberger, Nandita Mitra, Andrew J. Spieker · 2022 · Health Economics
  74. Cost-effectiveness of a transdiagnostic psychotherapy program for youth with common mental health problems
    Rasmus Trap Wolf, Pia Jeppesen, Mette Maria Agner Pedersen, Louise Berg Puggaard, Mikael Thastum, Niels Bilenberg, Per Hove Thomsen, Wendy K. Silverman, Kerstin Jessica Plessen, Simon‐Peter Neumer et al. · 2022 · BMC Health Services Research
  75. A Bayesian Net Benefit Approach to Cost‐effectiveness Analysis in Health Technology Assessment
    Elı́as Moreno, Francisco Javier Girón, Francisco José Vázquez Polo, Miguel Ángel Negrín · 2009 · International Journal of the Economics of Business
  76. Optimal treatments in cost-effectiveness analysis in the presence of covariates: Improving patient subgroup definition
    Elı́as Moreno, Francisco Javier Girón, M. L. Martínez, Francisco José Vázquez Polo, Miguel Ángel Negrín · 2012 · European Journal of Operational Research
  77. Acknowledging patient heterogeneity in health technology assessment
    Bram L. T. Ramaekers, Janneke P.C. Grutters, Manuela A. Joore · 2014 · Research Publications (Maastricht University)
  78. Dealing with uncertainty in the economic evaluation of health care technologies
    Susan C. Griffin · 2010 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  79. Incorporating patients' characteristics in cost-effectiveness studies with clinical trial data: a flexible Bayesian approach
    Francisco José Vázquez Polo, Miguel Ángel Negrín · 2004 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  80. Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life
    Keetharuth, Anju D., Gould, Rebecca L., McDermott, Christopher J., Thompson, Benjamin J., Rawlinson, Charlotte, Bradburn, Mike, Bursnall, Matt, Kumar, Pavithra, Turton, Emily J., Tappenden, Paul et al. · 2024 · European Journal of Neurology
  81. Cost-utility of computed tomography in patients with atypical chest pain clinically referred for invasive coronary angiography: randomised controlled trial
    Maria Bosserdt, Mahmoud M. A. Mohamed, Konrad Neumann, Nina Rieckmann, Henryk Dreger, Valentin Brodszky, Stefan Höfer, Thomas Reinhold, A.M. Mielke, Marc Dewey · 2025 · European Radiology
  82. Cost-Effectiveness of an Interdisciplinary, Internet-Based Transgender Health Care Program in Germany: Economic Evaluation Alongside a Randomized Controlled Trial
    Thomas Grochtdreis, Hans‐Helmut König, Janis Renner, Susanne Sehner, Arne Dekker, Peer Briken, Timo Ole Nieder, Judith Dams · 2025 · Journal of Medical Internet Research
  83. Sugammadex or Neostigmine for prevention of post-operative pulmonary complications after major abdominal or thoracic surgery: study protocol for the SINFONIA (Sugammadex for preventioN oF pOst-operative pulmonary complIcAtions) randomised controlled superiority trial
    Jonathan A. Silversides, Louise C. Savic, Louise Hiller, Amy Hopkins, Katie Booth, Jennifer Dorey, Richard Smithson, James M. Mason, Samuel Frempong, Christina May et al. · 2025 · Trials
  84. The economic value of empowering older patients transitioning from hospital to home: evidence from the ‘Your Care Needs You’ intervention
    Alfredo Palacios, Simon Walker, Beth Woods, Catherine Elizabeth Hewitt, Alison L. Cracknell, Jenni Murray, Rebecca Lawton, Gerry A. Richardson · 2025 · Age and Ageing
  85. Design and rationale of the Botswana Smoking Abstinence Reinforcement Trial: a protocol for a stepped-wedge cluster randomized trial
    Florence O. Bada, Megan E. Mansfield, Lillian A. Okui, Milton Montebatsi, Carlo C. DiClemente, Roy Tapera, Kaizer Ikgopoleng, Selebaleng V. Mokonopi, Jessica F. Magidson, Eberechukwu Onukwugha et al. · 2024 · Implementation Science Communications
  86. Cost-utility and cost–benefit analysis of a multi-component intervention (NEXpro) for neck-related symptoms in Swiss office workers
    Beatrice Brunner, Andrea Martina Aegerter, Venerina Johnston, Thomas Volken, Manja E. Deforth, Gisela Sjøgaard, Achim Elfering, Markus Melloh, Marco Barbero, Jon Cornwall et al. · 2025 · BMC Public Health
  87. Seemingly unrelated Bayesian additive regression trees for cost-effectiveness analyses in healthcare
    Jonas Eßer, Mateus Maia, Andrew C. Parnell, Judith Ekkina Bosmans, Johanna Maria van Dongen, Thomas L. T. Klausch, Keefe Murphy · 2025 · The Annals of Applied Statistics
  88. Cost-Effectiveness of Manual Therapy Versus Physical Therapy In Patients With Sub-Acute and Chronic Neck Pain: A Randomized Controlled Trial
    Johanna Maria van Dongen, Ruud Groeneweg, Sidney M. Rubinstein, Judith Ekkina Bosmans, RA Oostendorp, Raymond Ostelo, Maurits W. van Tulder · 2015 · Value in Health
  89. A review of heath economic evaluation practice in the Netherlands: are we moving forward?
    Andrea Gabrio · 2023 · Health Economics Policy and Law
  90. Cost-effectiveness of data driven personalised antibiotic dosing in critically ill patients with sepsis or septic shock
    Hana Marie Broulíková, Jacqueline Wallage, Luca F. Roggeveen, Lucas M. Fleuren, Tingjie Guo, Paul Elbers, Judith Ekkina Bosmans · 2025 · Journal of Clinical Monitoring and Computing
  91. COSTS' BEHAVIOR: SELECTION OF A LITERATURE REVIEW MATERIAL AND BIBLIOMETRIC ANALYSIS
    Sandra Rolim Enssiln, Altair Borgert, Universitário Reitor, João David, Ferreira Lima, Leonardo Ensslin, Aline Willemann Kremer · 2014
  92. Cost‐Effectiveness Analysis
    Morven N. Leese · 2008 · Wiley Encyclopedia of Clinical Trials
  93. The Case for Stratified Cost-Effectiveness Analysis by Baseline Health-Related QOL
    Joseph Schaafsma · 2005 · PharmacoEconomics
  94. Using copulas to estimate reduced-form systems of equations
    Casey Quinn · 2007 · RePEc: Research Papers in Economics
  95. Cost-effectiveness of adding psychomotor therapy to a multidisciplinary rehabilitation program for chronic pain
    L. van der Maas, Judith Ekkina Bosmans, Maurits W. van Tulder, Thomas W. J. Janssen · 2020 · Global & Regional Health Technology Assessment
  96. Supporting self-care for eczema in the community: the Eczema Care Online research programme including two RCTs
    Ingrid Müller, Beth L. Stuart, Tracey Sach, Lucy Yardley, Kate Greenwell, Taeko Becque, Paul A. Leighton, Laura Howells, Jane Harvey, Julie Hooper et al. · 2025 · Programme Grants for Applied Research
  97. Improving older people’s experiences and safety at transitions of care: the PACT mixed-methods study including RCT
    Jenni Murray, Ruth Baxter, Jane Kathryn O'Hara, Laura Sheard, Catherine Elizabeth Hewitt, Natasha Hardicre, Charles A. Vincent, Eirini Oikonomou, Gerry A. Richardson, Rosemary Shannon et al. · 2025 · Programme Grants for Applied Research
  98. The Cost-Effectiveness of Collagenase Injection Versus Limited Fasciectomy for Moderate Dupuytren’s Contracture: An Economic Evaluation of the Dupuytren’s Interventions Surgery Versus Collagenase Trial and a Decision Analytical Model
    Qi Wu, Catherine Arundel, Charlie Welch, Puvan Tharmanathan, Nick A. Johnson, Belén Corbacho, Joseph J. Dias, Maria Armaou, Christopher Bainbridge, John Cooke et al. · 2025 · Value in Health
  99. Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial
    William C.Y. Leung, Helen Kathryn Reddel, Tiffany Hung, Mark Weatherall, Ilka Pelzer, Mark Holliday, Trudy A. Sullivan, Tim W Harrison, Ian Douglas Pavord, Michael George Baker et al. · 2025 · ERJ Open Research
  100. Protocolized Evaluation of Permissive Blood Pressure Targets Versus Usual Care (PRESSURE): Statistical Analysis Plan for the PRESSURE Trial
    Tommaso Viola, Julia M. Broomhall, Zia Sadique, Paul Mouncey, David A Harrison, David Philip Inwald, for the Protocolized Evaluation of Permissive Blood Pressure Targets vs. Usual Care (PRESSURE) trial investigators on behalf of the Paediatric Critical Care Society Study Group (PCCS-SG) · 2026 · Pediatric Critical Care Medicine